[go: up one dir, main page]

HUE053272T2 - Multivalent conjugate pneumococcal vaccine - Google Patents

Multivalent conjugate pneumococcal vaccine

Info

Publication number
HUE053272T2
HUE053272T2 HUE16753710A HUE16753710A HUE053272T2 HU E053272 T2 HUE053272 T2 HU E053272T2 HU E16753710 A HUE16753710 A HU E16753710A HU E16753710 A HUE16753710 A HU E16753710A HU E053272 T2 HUE053272 T2 HU E053272T2
Authority
HU
Hungary
Prior art keywords
pneumococcal vaccine
multivalent conjugate
conjugate pneumococcal
multivalent
vaccine
Prior art date
Application number
HUE16753710A
Other languages
Hungarian (hu)
Inventor
Ramesh Venkat Matur
Nagarajan Thirumeni
Rajendar Burki
Narender Mantena
Mahima Datla
Original Assignee
Biological E Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biological E Ltd filed Critical Biological E Ltd
Publication of HUE053272T2 publication Critical patent/HUE053272T2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
HUE16753710A 2015-06-23 2016-06-21 Multivalent conjugate pneumococcal vaccine HUE053272T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3140CH2015 2015-06-23

Publications (1)

Publication Number Publication Date
HUE053272T2 true HUE053272T2 (en) 2021-06-28

Family

ID=56738144

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16753710A HUE053272T2 (en) 2015-06-23 2016-06-21 Multivalent conjugate pneumococcal vaccine

Country Status (22)

Country Link
US (1) US11147863B2 (en)
EP (1) EP3313436B1 (en)
JP (1) JP6808658B2 (en)
CN (1) CN107810010A (en)
AU (1) AU2016285017B2 (en)
BR (1) BR112017028130A2 (en)
CY (1) CY1123838T1 (en)
DK (1) DK3313436T3 (en)
EA (1) EA037373B1 (en)
ES (1) ES2857474T3 (en)
HR (1) HRP20210373T1 (en)
HU (1) HUE053272T2 (en)
LT (1) LT3313436T (en)
MX (1) MX389480B (en)
PL (1) PL3313436T3 (en)
PT (1) PT3313436T (en)
RS (1) RS61440B1 (en)
SA (1) SA517390539B1 (en)
SI (1) SI3313436T1 (en)
SM (1) SMT202100121T1 (en)
WO (1) WO2016207905A2 (en)
ZA (1) ZA201708713B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11160855B2 (en) * 2014-01-21 2021-11-02 Pfizer Inc. Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR102225282B1 (en) * 2015-07-21 2021-03-10 화이자 인코포레이티드 Immunogenic composition comprising conjugated capsular saccharide antigen, kit comprising same, and use thereof
US11058757B2 (en) 2016-03-31 2021-07-13 Pogona, LLC Saccharide-polypeptide conjugate compositions and methods of use thereof
AU2017336806B2 (en) * 2016-09-30 2024-06-27 Biological E Limited Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
ES3024474T3 (en) 2016-12-30 2025-06-04 Vaxcyte Inc Polypeptide-antigen conjugates with non-natural amino acids
EP3634481A4 (en) * 2017-06-10 2021-07-21 Inventprise, LLC. MULTIVALENT CONJUGATE VACCINES WITH BIVALENT OR MULTIVALENT CONJUGATE POLYSACCHARIDES THAT PROVIDE IMPROVED IMMUNOGENICITY AND AVIDITY
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
EP3691677A4 (en) 2017-10-04 2021-07-07 Pogona, Llc SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHOD OF USING THEREOF
CN108003240B (en) * 2017-12-04 2020-06-05 西安德轩驰生物科技有限公司 Multi-connected anti-idiotype egg yolk antibody vaccine for marine cultured fish and preparation method thereof
US11116828B2 (en) 2017-12-06 2021-09-14 Merck Sharp & Dohme Corp. Compositions comprising Streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
AU2019215216B2 (en) 2018-02-05 2025-04-17 Sk Bioscience Co., Ltd. Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218B2 (en) 2018-04-18 2025-10-16 Sk Bioscience Co., Ltd. Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
JP7558944B2 (en) * 2018-10-12 2024-10-01 バイオロジカル イー リミテッド Multivalent pneumococcal polysaccharide-protein conjugate vaccine
GEP20247633B (en) 2018-12-19 2024-06-25 Merck Sharp & Dohme Llc Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
EP3900739A1 (en) 2020-04-21 2021-10-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synthetic streptococcus pneumoniae saccharide conjugates to conserved membrane protein

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360897A (en) 1981-08-31 1994-11-01 The University Of Rochester Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
ATE245446T1 (en) 1992-02-11 2003-08-15 Jackson H M Found Military Med DUAL CARRIER FOR IMMUNOGENIC CONSTRUCTS
PT616034E (en) 1993-03-05 2005-02-28 Wyeth Corp PLASMIDEO FOR THE PRODUCTION OF PROTEIN CRM AND DIPHTHERIA TOXIN
JP3828145B2 (en) 1993-09-22 2006-10-04 ヘンリー エム.ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン A method for the activation of soluble carbohydrates using a novel cyanating reagent for the production of immunogenic components
ATE241384T1 (en) 1995-03-22 2003-06-15 Jackson H M Found Military Med PREPARATION OF IMMUNOGENIC CONSTRUCTS USING SOLUBLE CARBOHYDRATES ACTIVATED BY ORGANIC CYANYLATION REAGENTS
FR2763244B1 (en) 1997-05-14 2003-08-01 Pasteur Merieux Serums Vacc MULTIVALENT VACCINE COMPOSITION WITH MIXED CARRIER
US8048432B2 (en) 2003-08-06 2011-11-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Polysaccharide-protein conjugate vaccines
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
CN104815327A (en) 2005-04-08 2015-08-05 惠氏有限责任公司 Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
PT1973564T (en) * 2005-12-22 2017-01-24 Glaxosmithkline Biologicals Sa Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
KR20150038626A (en) 2006-03-17 2015-04-08 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 Methods for preparing complex multivalent immunogenic conjugates
AU2008267208B2 (en) * 2007-06-26 2012-01-19 Glaxosmithkline Biologicals S.A. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CN101590224A (en) 2009-06-30 2009-12-02 广州精达医学科技有限公司 High-efficiency 14-valent pneumococcal conjugate vaccine
TW201136603A (en) * 2010-02-09 2011-11-01 Merck Sharp & Amp Dohme Corp 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB201003924D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
KR102057217B1 (en) 2012-06-20 2020-01-22 에스케이바이오사이언스 주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN103623401A (en) 2012-08-23 2014-03-12 北京科兴中维生物技术有限公司 Multivalent pneumococcus capsular polysaccharide-protein conjugated composition and preparation method thereof
CN103656631B (en) 2012-09-24 2015-08-19 北京科兴中维生物技术有限公司 multivalent pneumococcal capsular polysaccharide-protein conjugate composition and preparation method thereof
CN103656632B (en) 2012-09-24 2016-01-13 北京科兴中维生物技术有限公司 Multivalent pneumococcal capsular polysaccharide composition, its preparation method and application
KR20140075201A (en) * 2012-12-11 2014-06-19 에스케이케미칼주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
KR20140075196A (en) 2012-12-11 2014-06-19 에스케이케미칼주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
CN104069488A (en) 2013-03-29 2014-10-01 北京科兴中维生物技术有限公司 Multivalent pneumococcus capsular polysaccharide-protein conjugated composition and preparation method thereof
MX388191B (en) 2014-11-20 2025-03-19 Biological E Ltd CODON-OPTIMIZED POLYNUCLEOTIDE FOR HIGH-LEVEL EXPRESSION OF CRM197.

Also Published As

Publication number Publication date
HRP20210373T1 (en) 2021-04-30
ZA201708713B (en) 2019-08-28
SMT202100121T1 (en) 2021-05-07
RS61440B1 (en) 2021-03-31
PL3313436T3 (en) 2021-06-14
EP3313436B1 (en) 2020-12-23
JP2018518512A (en) 2018-07-12
ES2857474T3 (en) 2021-09-29
AU2016285017B2 (en) 2022-03-03
WO2016207905A3 (en) 2017-02-09
SA517390539B1 (en) 2021-05-24
AU2016285017A1 (en) 2018-01-04
MX389480B (en) 2025-03-20
JP6808658B2 (en) 2021-01-06
EA037373B1 (en) 2021-03-22
SI3313436T1 (en) 2021-09-30
BR112017028130A2 (en) 2018-08-28
CN107810010A (en) 2018-03-16
EP3313436A2 (en) 2018-05-02
LT3313436T (en) 2021-06-10
DK3313436T3 (en) 2021-03-08
US11147863B2 (en) 2021-10-19
PT3313436T (en) 2021-02-25
CY1123838T1 (en) 2022-05-27
CA2989230A1 (en) 2016-12-29
MX2017016828A (en) 2018-09-18
EA201890431A1 (en) 2018-06-29
WO2016207905A2 (en) 2016-12-29
US20190240308A1 (en) 2019-08-08

Similar Documents

Publication Publication Date Title
IL281204A (en) Multivalent pneumococcal vaccines
HUE053272T2 (en) Multivalent conjugate pneumococcal vaccine
NO2022035I1 (en) Pneumococcal polysaccharide serotype 22F conjugated to CRM197 carrier protein
IL265623A (en) Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
EP3732205A4 (en) MULTIVALENT CHIMERAIR ANTIGEN RECEPTOR
PT3585803T (en) Pneumococcal Conjugate Vaccine Formulations
IL253187A0 (en) Novel multivalent nanoparticle-based vaccines
ZA201901346B (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
IL256118A (en) Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained from them
DK3393510T5 (en) ZIKAVIRUS VACCINE
SG11201505889RA (en) Multivalent glycoconjugate vaccines
ZA201901345B (en) Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3273989C0 (en) STREPTOCOCCAL VACCINE
IL277274A (en) Multivalent influenza nanoparticle vaccines
ZA201800928B (en) Multivalent vlp conjugates
ZA201607355B (en) Group a streptococcus vaccine
IL264605A (en) A multivalent vaccine
EP3511016A4 (en) IMMUNOSTIMULANT
EP3439693A4 (en) Novel pneumococcal vaccine formulations
IL252416B (en) Multivalent ligand-lipid constructs
EP3706787A4 (en) VACCINE
HK40046980A (en) Multivalent pneumococcal vaccines
IL262510A (en) Reoviridae vaccine
GB201410060D0 (en) Multivalent and monovalent vaccines
TH1501005930A (en) WT1 antigen peptide conjugate vaccine